查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
复合药房市场，按产品类型、按应用、按治疗领域、按复合类型、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1351423

复合药房市场，按产品类型、按应用、按治疗领域、按复合类型、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Compounding Pharmacies Market, By Product Type, By Application, By Therapeutic areas, By Compounding Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 248 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，复合药局市场规模为 126.087 亿美元，2023 年至 2030 年复合年增长率为 6.3%。

复合药局市场 - 市场动态：

  • 慢性病盛行率上升、老年人口增加以及预期寿命延长预计将推动市场需求
  • 慢性疾病通常需要长期治疗。复方药房可以根据患者的独特需求调整药物，最大限度地提高剂量和剂型，或以其他方式提高药物的有效性或对有特殊需求的患者的耐受性。根据国家卫生委员会的数据，慢性病通常无法治癒且持续存在，影响约 1.33 亿美国人，占全国总人口的 40% 以上。到 2020 年，这一数字预计将增长至约 1.57 亿，其中 8,100 万人患有多种疾病。由于老年人越来越多，因此对专业老年护理的需求更大，无论是在针对该年龄层设计的医疗服务还是设施方面。随着预期寿命的延长，对确保生活品质的预防医学的重视也随之增加。这可能会加强健康、营养和筛检产业。发展中国家提供了重要的发展机会。随着这些领域的意识和收入水准的提高，对客製化治疗的需求可能会增加。然而，复方药局偶尔遇到的严格监管可能会带来问题。它阻碍了市场的成长。

复合药房市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，全球复合药局市场预计在预测期内（2023-2030 年）每年将以 6.3% 左右的复合年增长率成长
  • 由于人们对永续成长的认识不断增强，复合製药产业预计将以显着的速度成长
  • 根据产品类型细分，预计 Oral 将在 2022 年显示最大的市场份额
  • 根据治疗领域细分，荷尔蒙替代疗法（HRT）是2022年的主导类型
  • 从应用细分来看，2022年老年医学为主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

复合药房市场細項分析：

  • 全球复合药房市场根据产品类型、治疗领域、应用、复合类型和地区进行细分。
  • 根据产品类型，市场分为七类：口服、外用、直肠、肠外、鼻腔、眼科和漱口水。口腔细分市场占据主导地位。由于其给药方便、患者依从性以及剂型的多样性（如片剂、胶囊、液体和混悬剂），口服途径仍然是最受欢迎的给药方式之一。
  • 市场根据治疗领域分为四大类：疼痛管理、荷尔蒙替代疗法（HRT）、皮肤科和特殊药物。荷尔蒙替代疗法（HRT）细分市场占据主导地位。复方药局在荷尔蒙替代疗法（HRT）领域发挥重要作用。 HRT 是使用荷尔蒙来治疗体内荷尔蒙异常，这种异常通常与更年期、男性更年期（有时称为「男性更年期」）或某些内分泌疾病有关。
  • 依应用市场分为四大类：儿科、成人、老年和兽医。老年应用程式在市场上占据主导地位，并可能在预测期内保持其主导地位。复方药局在老年保健领域发挥重要作用。由于多重用药（服用多种药物）、与年龄相关的生理变化、特定药物敏感性和药物管理问题等因素，老年人群经常有独特的处方需求。

复合药局市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。由于该地区对复合药物的认识较高以及医疗机构数量不断增加，预计北美将主导市场的成长。多年来，美国和加拿大在医疗基础设施方面进行了大量投资。这不仅涵盖医院，还涵盖专科诊所、疗养院和其他复合药物可能有益的护理机构。 《全球视野下的美国医疗保健》预测，2021年，美国医疗保健支出占国内生产毛额（GDP）的17.8%，几乎是经合组织国家平均水准的两倍。由于认知度高、监管明确、经济实力强和技术创新，欧洲是复方药房的第二大市场。

复合药局市场-竞争格局：

与许多行业一样，复方药房行业的竞争格局是由许多主要参与者、区域参与者和本地独立药房的存在决定的。这些组织经常在品质、服务范围、法规遵循、技术改进和地理覆盖范围等方面进行竞争。市场份额将根据每个公司占据的位置和复合领域的具体利基而有所不同。就收入而言，儘管当地独立药局可能在当地市场中占有主要份额，但拥有多个地点的大型企业可能会占据主导地位。

一些药房可能会利用技术改进来提高配製精度、品质控製或营运效率。例如，Avella Specialty Pharmacy 签署了一项最终协议，收购总部位于休士顿的Advanced Pharma Inc.，这是一家在FDA 註册的503B 外包机构，为全国医院、卫生系统和门诊手术中心提供14 个治疗类别的复合产品。

最近的发展：

2018年10月11日，费森尤斯·卡比宣布目前已在安大略省密西索加开设了一个新的药物配製中心。该中心拥有最先进的製造技术和工艺，旨在满足严格的品质标准和客户不断增长的产能需求。该工厂为加拿大医院生产复方药物。

目录

第 1 章：复合药局市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的复方药房市场片段
    • 按应用分類的复合药房市场片段
    • 按复合类型分類的复合药房市场片段
    • 按治疗领域分類的复合药房市场片段
    • 按国家/地区分類的复合药房市场片段
    • 按地区分類的复合药房市场片段
  • 竞争洞察

第 3 章：复合药局主要市场趋势

  • 复合药房市场驱​​动因素
    • 市场驱动因素的影响分析
  • 加剧药房市场限制
    • 市场限制影响分析
  • 复合药房市场机会
  • 复合药局市场未来趋势

第 4 章：复合药局产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：复合药局市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：复合药局市场格局

  • 2022 年复方药局市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：复合药局市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 口服
      • 胶囊
      • 平板电脑
      • 混合物
      • 棒棒糖
      • 含片
    • 专题
      • 凝胶
      • 药膏
      • 奶油
      • 乳液
    • 直肠
    • 注射用
    • 鼻腔
    • 眼科
    • 漱口水

第 8 章：复合药局市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 儿科
    • 成年人
    • 老年科
    • 兽医

第 9 章：复合药局市场 - 按复方类型

  • 概述
    • 按复合类型分類的细分市场份额分析
    • 药物成分变更 (PIA)
    • 目前无法使用的药品製造 (CUPM)
    • 药物剂量变更 (PDA)
    • 其他的

第 10 章：复合药房市场 - 按治疗领域

  • 概述
    • 按应用的细分市场占有率分析
    • 疼痛管理
    • 荷尔蒙替代疗法 (HRT)
    • 皮肤科
    • 特殊药物

第 11 章：复合药局市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美复合药房主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按复合类型）
    • 北美市场规模与预测（按治疗领域）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲复方药房主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按复利类型）
    • 欧洲市场规模与预测（按治疗领域）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区复方药局主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依复利类型）
    • 按治疗领域分類的亚太市场规模和预测
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲复合药房主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按复合类型）
    • 拉丁美洲市场规模与预测（按治疗领域）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲复合药房主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按复合类型）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 复合药局产业

  • 竞争仪表板
  • 公司简介
    • Avella Specialty Pharmacy
    • Central Admixture Pharmacy Services
    • Fagron
    • Fresenius Kabi AG
    • PharMEDium Services
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Triangle Compounding Pharmacies
    • Lorraine's Pharmacy
    • Rx3 Compounding Pharmacy
    • B Braun Melsungen AG
    • Clinigen Group PLC
    • QuVa Pharma
    • ITC Compounding Pharmacy
    • Advanced Pharmacy.

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1658

REPORT HIGHLIGHT

Compounding Pharmacies Market size was valued at USD 12,608.7 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.

Compounding pharmacies have a unique and crucial function in the pharmaceutical sector. By blending, modifying, or combining two or more substances to match a patient's unique needs, pharmacists create customized prescriptions for their patients. In order to create a compounded medicine, compounding pharmacies must use only pure, pharmaceutical-grade ingredients. These have to be manufactured in a setting that has an FDA registration. Compound and conventional medications are labeled differently in several cases. unlike labels for FDA-approved pharmaceuticals, compounded medicine labels don't adhere to a specific structure. The laws governing them differ as well.

Compounding Pharmacies Market - Market Dynamics:

  • Increasing prevalence of chronic disease, increase in old age population, and improved life expectancy expected to propel market demand
  • Long-term treatment is frequently necessary for chronic disorders. Compounding pharmacies can adapt pharmaceuticals to a patient's unique requirements, maximizing dosages and forms, or otherwise improving their effectiveness or tolerability for patients with particular demands. According to the National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. There is a greater need for specialist geriatric care as there are more senior people, both in terms of medical services and facilities designed for this age group. The emphasis on preventative medicine to ensure quality of life grows as life expectancy rises. This may strengthen the wellness, nutrition, and screening industries. Significant opportunity for development is offered by developing nations. The need for customized treatments could increase as awareness and income levels improve in these areas. However, the severe regulatory supervision that compounding pharmacies occasionally experience can be problematic. It hampers the market growth.

Compounding Pharmacies Market - Key Insights:

  • As per the analysis shared by our research analyst, the global Compounding Pharmacies market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)
  • The Compounding Pharmacies industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product type segmentation, Oral was predicted to show maximum market share in the year 2022
  • Based on Therapeutic Area segmentation, Hormone Replacement Therapy (HRT) was the leading type in 2022
  • Based on Application segmentation, Geriatric was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Compounding Pharmacies Market- Segmentation Analysis:

  • The Global Compounding Pharmacies Market is segmented based on Product Type, Therapeutic Areas, Application, Compounding Type, and Region.
  • The market is divided into seven categories based on product type: Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Mouthwashes. The oral segment dominates the market. Due to its ease of administration, patient compliance, and diversity in formulation (such as tablets, capsules, liquids, and suspensions), the oral route remains one of the most popular drug delivery modalities.
  • The market is divided into four categories based on Therapeutic Areas: Pain Management, Hormone Replacement Therapy (HRT), Dermatology, and Specialty Drugs. Hormone Replacement Therapy (HRT) segment dominates the market. Compounding pharmacies play an important part in the field of Hormone Replacement Therapy (HRT). HRT is the use of hormones to treat hormonal abnormalities in the body, which are frequently associated with menopause, andropause (sometimes known as "male menopause"), or certain endocrine illnesses.
  • The market is divided into four categories based on Application: Pediatric, adult, Geriatric, and Veterinary. The Geriatric application dominates the market and is likely to maintain its dominance during the forecast period. Compounding pharmacies play an important part in the geriatric healthcare sector. Because of factors such as polypharmacy (taking numerous medications), age-related physiological changes, specific drug sensitivities, and drug administration problems, the aged population frequently has unique prescription needs.

Compounding Pharmacies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to High regional awareness regarding compounding medications, and an increasing number of healthcare facilities. Over the years, the US and Canada have made considerable investments in healthcare infrastructure. This covers not only hospitals but also specialty clinics, nursing homes, and other care settings where compounded pharmaceuticals can be beneficial. The U.S. Health Care from a Global Perspective predicted that in 2021, the U.S. spent 17.8 percent of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. Europe is the second-largest market for Compounding Pharmacies, due to high awareness, regulatory clarity, economic strength, and technological innovation.

Compounding Pharmacies Market- Competitive Landscape:

As with many sectors, the competitive landscape of the compounding pharmacies industry is defined by the existence of many main players, regional players, and local, independent pharmacies. These organizations frequently compete on the basis of quality, service range, regulatory compliance, technical improvements, and geographic coverage. The market share will differ depending on the location and the precise niche within compounding that each company occupies. In terms of revenue, larger businesses with several locations may dominate, although local, independent pharmacies may hold major shares in local marketplaces.

Some pharmacies may use technology improvements to improve compounding precision, quality control, or operational efficiency. For Example, Avella Specialty Pharmacy has signed a definitive agreement to acquire Houston-based Advanced Pharma Inc., an FDA-registered 503B outsourcing facility providing compounded products across 14 therapeutic classes to hospitals, health systems, and ambulatory surgery centers nationwide.

Recent Developments:

On Oct. 11, 2018, Fresenius Kabi announced currently it has opened a new pharmaceutical compounding center in Mississauga, Ontario. The center features state-of-the-art manufacturing technology and processes designed to meet rigorous quality standards and increased capacity needs of customers. The facility produces compounded pharmaceuticals for Canadian hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPOUNDING PHARMACIES MARKET KEY PLAYERS

  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services
  • Fagron
  • Fresenius Kabi AG
  • PharMEDium Services
  • Institutional Pharmacy Solutions
  • Cantrell Drug Company
  • Triangle Compounding Pharmacies
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • B Braun Melsungen AG
  • Clinigen Group PLC
  • QuVa Pharma
  • ITC Compounding Pharmacy
  • Advanced Pharmacy

GLOBAL COMPOUNDING PHARMACIES MARKET, BY PRODUCT TYPE

  • Oral
  • Capsule
  • Tablets
  • Mixtures
  • Lollipops
  • Lozenges
  • Topical
  • Gels
  • Ointments
  • Cream
  • Lotions
  • Rectal
  • Parenteral
  • Nasal
  • Ophthalmic
  • Mouthwashes

GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA

  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Dermatology
  • Specialty Drugs

GLOBAL COMPOUNDING PHARMACIES MARKET, BY APPLICATION

  • Pediatric
  • Adults
  • Geriatric
  • Veterinary

GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE

  • Pharmaceutical Ingredient Alteration (PIA)
  • Pharmaceutical Dosage Alteration (PDA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Others

GLOBAL COMPOUNDING PHARMACIES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Compounding Pharmacies Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Compounding Pharmacies Market Snippet by Product Type
    • 2.1.2. Compounding Pharmacies Market Snippet by Application
    • 2.1.3. Compounding Pharmacies Market Snippet by Compounding Type
    • 2.1.4. Compounding Pharmacies Market Snippet by Therapeutic Areas
    • 2.1.5. Compounding Pharmacies Market Snippet by Country
    • 2.1.6. Compounding Pharmacies Market Snippet by Region
  • 2.2. Competitive Insights

3. Compounding Pharmacies Key Market Trends

  • 3.1. Compounding Pharmacies Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Compounding Pharmacies Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Compounding Pharmacies Market Opportunities
  • 3.4. Compounding Pharmacies Market Future Trends

4. Compounding Pharmacies Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Compounding Pharmacies Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Compounding Pharmacies Market Landscape

  • 6.1. Compounding Pharmacies Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Compounding Pharmacies Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Oral
      • 7.1.2.1. Capsule
      • 7.1.2.2. Tablets
      • 7.1.2.3. Mixtures
      • 7.1.2.4. Lollipops
      • 7.1.2.5. Lozenges
    • 7.1.3. Topical
      • 7.1.3.1. Gels
      • 7.1.3.2. Ointments
      • 7.1.3.3. Cream
      • 7.1.3.4. Lotions
    • 7.1.4. Rectal
    • 7.1.5. Parenteral
    • 7.1.6. Nasal
    • 7.1.7. Ophthalmic
    • 7.1.8. Mouthwashes

8. Compounding Pharmacies Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Pediatric
    • 8.1.3. Adults
    • 8.1.4. Geriatric
    • 8.1.5. Veterinary

9. Compounding Pharmacies Market - By Compounding Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Compounding Type, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Ingredient Alteration (PIA)
    • 9.1.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
    • 9.1.4. Pharmaceutical Dosage Alteration (PDA)
    • 9.1.5. Others

10. Compounding Pharmacies Market - By Therapeutic Areas

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Pain Management
    • 10.1.3. Hormone Replacement Therapy (HRT)
    • 10.1.4. Dermatology
    • 10.1.5. Specialty Drugs

11. Compounding Pharmacies Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Compounding Pharmacies Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Compounding Pharmacies Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Compounding Pharmacies Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Compounding Pharmacies Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Compounding Pharmacies Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Compounding Pharmacies Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Avella Specialty Pharmacy
    • 12.2.2. Central Admixture Pharmacy Services
    • 12.2.3. Fagron
    • 12.2.4. Fresenius Kabi AG
    • 12.2.5. PharMEDium Services
    • 12.2.6. Institutional Pharmacy Solutions
    • 12.2.7. Cantrell Drug Company
    • 12.2.8. Triangle Compounding Pharmacies
    • 12.2.9. Lorraine's Pharmacy
    • 12.2.10. Rx3 Compounding Pharmacy
    • 12.2.11. B Braun Melsungen AG
    • 12.2.12. Clinigen Group PLC
    • 12.2.13. QuVa Pharma
    • 12.2.14. ITC Compounding Pharmacy
    • 12.2.15. Advanced Pharmacy.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Compounding Pharmacies Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Compounding Pharmacies Market, by Product Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Compounding Pharmacies Market, by Application 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Compounding Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Compounding Type
  • TABLE Global Compounding Pharmacies Market, by Compounding Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Therapeutic Areas Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Compounding Pharmacies Market, by Therapeutic Areas 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Compounding Pharmacies Market, by Region 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)